ArticleScientific reports2025
Comparative analysis of key phytochemicals and biological activities of Tartary buckwheat and Flos Sophorae Immaturus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Flavonoids such as rutin, quercetin, and kaempferol are the major bioactive compounds in Tartary buckwheat (TB) and Flos Sophorae Immaturus (FSI), contributing to various health benefits such as anti-cancer, antioxidant, antiviral, antithrombotic, analgesic, anti-aging, antibacterial, anti-inflammatory, and anti-allergic. This study developed a method to detect and identify characteristic compounds in Tartary buckwheat extracts and compared the key ingredients and biological activities of Tartary buckwheat and Flos Sophorae Immaturus. High-performance liquid chromatography (HPLC) identified major components by comparing their chromatographic profiles with standard compounds. Furthermore, the biological activities, including antioxidant capacity, α-glucosidase inhibition, lipase inhibition, and cytoprotective effects against alcohol-induced liver injury in vitro, were systematically evaluated. The results showed that quercetin-3-rutinoside-7-glucoside was identified as the characteristic compound of Tartary buckwheat, distinguishing it from Flos Sophorae Immaturus. While antioxidant activities were similar, Tartary buckwheat extract showed significantly stronger α-glucosidase and lipase inhibitory activities and enhanced cytoprotective effects against alcohol-induced liver injury. These findings highlight the superior hypoglycemic, hypolipidemic, and hepatoprotective effects of Tartary buckwheat extract and its key flavonoid, quercetin-3-rutinoside-7-glucoside (QRG), compared to Flos Sophorae Immaturus extract, suggesting their potential for functional foods or therapeutic applications targeting metabolic disorders and liver protection. Further research should explore their mechanisms and validate efficacy in vivo and potential applications in Tartary Buckwheat and Flos Sophorae Immaturus based functional foods and nutraceuticals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.